Menu
GeneBe

ACADSB

acyl-CoA dehydrogenase short/branched chain, the group of Acyl-CoA dehydrogenase family

Basic information

Region (hg38): 10:123008978-123058290

Links

ENSG00000196177NCBI:36OMIM:600301HGNC:91Uniprot:P45954AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • 2-methylbutyryl-CoA dehydrogenase deficiency (Strong), mode of inheritance: AR
  • 2-methylbutyryl-CoA dehydrogenase deficiency (Strong), mode of inheritance: AR
  • 2-methylbutyryl-CoA dehydrogenase deficiency (Moderate), mode of inheritance: AR
  • 2-methylbutyryl-CoA dehydrogenase deficiency (Supportive), mode of inheritance: AR
  • 2-methylbutyryl-CoA dehydrogenase deficiency (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
2-methylbutyryl-CoA dehydrogenase deficiencyARGeneralThe clinical relevance of the condition is unclear, though some have stated that special attention may be necessary in situations involving potential metabolic decompensationBiochemical10832746; 12837870; 16317551; 17883863; 17945527; 20547083; 21290185

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ACADSB gene.

  • Deficiency of 2-methylbutyryl-CoA dehydrogenase (236 variants)
  • not provided (50 variants)
  • ACADSB-related condition (4 variants)
  • Inborn genetic diseases (4 variants)
  • not specified (2 variants)
  • Seizure (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACADSB gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
19
clinvar
5
clinvar
26
missense
4
clinvar
2
clinvar
59
clinvar
3
clinvar
68
nonsense
1
clinvar
4
clinvar
5
start loss
1
clinvar
1
frameshift
4
clinvar
4
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
4
clinvar
1
clinvar
5
splice region
1
8
4
1
14
non coding
62
clinvar
22
clinvar
51
clinvar
135
Total 5 14 126 41 59

Highest pathogenic variant AF is 0.0000526

Variants in ACADSB

This is a list of pathogenic ClinVar variants found in the ACADSB region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-123008986-G-T Uncertain significance (Jun 24, 2021)1678479
10-123008991-G-A Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (Jan 12, 2018)299066
10-123009002-G-T Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (Jan 13, 2018)878311
10-123009008-A-G Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (Jan 12, 2018)299067
10-123009011-G-C Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (Jan 13, 2018)878892
10-123009030-A-T not specified Uncertain significance (Aug 02, 2023)2581200
10-123009035-G-A Deficiency of 2-methylbutyryl-CoA dehydrogenase Likely benign (Jun 15, 2022)2001202
10-123009037-G-A Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (Aug 01, 2022)2195993
10-123009037-G-C Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (Jun 22, 2022)2009469
10-123009042-G-A Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (Aug 27, 2021)1348511
10-123009049-G-T Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (Oct 10, 2020)1037854
10-123009067-G-A Deficiency of 2-methylbutyryl-CoA dehydrogenase Benign (Feb 01, 2024)299068
10-123009071-G-A Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (Jan 16, 2018)536347
10-123009071-G-T Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (Jan 13, 2018)299069
10-123009383-G-C Benign (Jul 09, 2018)1249547
10-123034081-A-G Benign (Jul 09, 2018)1180240
10-123034198-C-CA Benign (Oct 02, 2019)1258728
10-123034358-A-C Deficiency of 2-methylbutyryl-CoA dehydrogenase Benign (Apr 29, 2021)796631
10-123034378-G-GT Deficiency of 2-methylbutyryl-CoA dehydrogenase Likely pathogenic (Jan 08, 2024)3075976
10-123034380-T-G Deficiency of 2-methylbutyryl-CoA dehydrogenase • ACADSB-related disorder Conflicting classifications of pathogenicity (Jul 12, 2022)654197
10-123034392-A-G Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (Jul 30, 2022)1897714
10-123034405-A-G Deficiency of 2-methylbutyryl-CoA dehydrogenase • ACADSB-related disorder Benign (Feb 01, 2024)299070
10-123034408-T-A Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (Jan 13, 2018)299071
10-123034467-G-A Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (May 22, 2023)947014
10-123034470-C-T Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain significance (Jul 21, 2022)1514895

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ACADSBprotein_codingprotein_codingENST00000358776 1149333
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.66e-110.26312553702111257480.000839
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.06972302271.010.00001102789
Missense in Polyphen8991.5670.971971143
Synonymous0.5387884.30.9250.00000447818
Loss of Function0.9101923.80.7990.00000109312

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.003090.00309
Ashkenazi Jewish0.00009920.0000992
East Asian0.002720.00272
Finnish0.0001390.000139
European (Non-Finnish)0.0007570.000756
Middle Eastern0.002720.00272
South Asian0.0001960.000196
Other0.0008160.000815

dbNSFP

Source: dbNSFP

Function
FUNCTION: Has greatest activity toward short branched chain acyl- CoA derivative such as (s)-2-methylbutyryl-CoA, isobutyryl-CoA, and 2-methylhexanoyl-CoA as well as toward short straight chain acyl-CoAs such as butyryl-CoA and hexanoyl-CoA. Can use valproyl- CoA as substrate and may play a role in controlling the metabolic flux of valproic acid in the development of toxicity of this agent.;
Pathway
Fatty acid degradation - Homo sapiens (human);Valine, leucine and isoleucine degradation - Homo sapiens (human);Valproic Acid Pathway, Pharmacokinetics;Long chain acyl-CoA dehydrogenase deficiency (LCAD);3-Methylglutaconic Aciduria Type I;Valine, Leucine and Isoleucine Degradation;2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;Trifunctional protein deficiency;Carnitine palmitoyl transferase deficiency (II);Very-long-chain acyl coa dehydrogenase deficiency (VLCAD);Medium chain acyl-coa dehydrogenase deficiency (MCAD);Isovaleric Aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;Propionic Acidemia;Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency);Fatty acid Metabolism;Maple Syrup Urine Disease;Valproic Acid Metabolism Pathway;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;Isobutyryl-coa dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-hydroxyisobutyric acid dehydrogenase deficiency;Isovaleric acidemia;Glutaric Aciduria Type I;Ethylmalonic Encephalopathy;Methylmalonate Semialdehyde Dehydrogenase Deficiency;Methylmalonic Aciduria;3-Methylglutaconic Aciduria Type IV;3-Methylglutaconic Aciduria Type III;Beta-Ketothiolase Deficiency;Carnitine palmitoyl transferase deficiency (I);Valproic acid pathway;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives;Saturated fatty acids beta-oxidation;Metabolism;Mono-unsaturated fatty acid beta-oxidation;Valine, leucine and isoleucine degradation;Propanoate metabolism;Dimethyl-branched-chain fatty acid mitochondrial beta-oxidation;isoleucine degradation (Consensus)

Recessive Scores

pRec
0.275

Intolerance Scores

loftool
0.294
rvis_EVS
-0.4
rvis_percentile_EVS
26.73

Haploinsufficiency Scores

pHI
0.507
hipred
N
hipred_score
0.197
ghis
0.472

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.872

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Acadsb
Phenotype

Gene ontology

Biological process
fatty acid metabolic process;branched-chain amino acid catabolic process;oxidation-reduction process
Cellular component
mitochondrion;mitochondrial matrix
Molecular function
acyl-CoA dehydrogenase activity;flavin adenine dinucleotide binding